Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-51,000
Closed -$46.9M 281
2016
Q1
$46.9M Hold
51,000
1.04% 25
2015
Q4
$52.6M Buy
51,000
+21,000
+70% +$21.1M 0.87% 40
2015
Q3
$28.3M Hold
30,000
0.43% 69
2015
Q2
$31.3M Buy
+30,000
New +$31.4M 0.29% 85

Other funds holding AGN.PRA

George Soros's AGN.PRA Position: Q2 2016 in Review

George Soros sold out of Allergan plc (AGN.PRA) in Q2 2016, closing a stake of 51,000 shares — an estimated $46.9M sold.

George Soros first reported a position in AGN.PRA in Q2 2015 and held it in 4 quarters. The position peaked at $52.6M in Q4 2015. 108 funds tracked by Wall St. Rank hold AGN.PRA as of Q2 2016.

  • George Soros reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • George Soros sold 51,000 Allergan plc shares in Q2 2016, an estimated $46.9M.
  • George Soros first reported a position in Allergan plc in Q2 2015 and held it in 4 quarters.
  • George Soros's Allergan plc position peaked at $52.6M in Q4 2015.
  • 108 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Soros Fund Management's 13F filing for Q2 2016, filed 15 Aug 2016.